STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling

ABSTRACT Smad proteins play a key role in the intracellular signaling of the transforming growth factor β (TGF-β) superfamily of extracellular polypeptides that initiate signaling from the cell surface through serine/threonine kinase receptors. A subclass of Smad proteins, including Smad6 and Smad7, has been shown to function as intracellular antagonists of TGF-β family signaling. We have previously reported the identification of a WD40 repeat protein, STRAP, that associates with both type I and type II TGF-β receptors and that is involved in TGF-β signaling. Here we demonstrate that STRAP synergizes specifically with Smad7, but not with Smad6, in the inhibition of TGF-β-induced transcriptional responses. STRAP does not show cooperation with a C-terminal deletion mutant of Smad7 that does not bind with the receptor and consequently has no inhibitory activity. STRAP associates stably with Smad7, but not with the Smad7 mutant. STRAP recruits Smad7 to the activated type I receptor and forms a complex. Moreover, STRAP stabilizes the association between Smad7 and the activated receptor, thus assisting Smad7 in preventing Smad2 and Smad3 access to the receptor. STRAP interacts with Smad2 and Smad3 but does not cooperate functionally with these Smads to transactivate TGF-β-dependent transcription. The C terminus of STRAP is required for its phosphorylation in vivo, which is dependent on the TGF-β receptor kinases. Thus, we describe a mechanism to explain how STRAP and Smad7 function synergistically to block TGF-β-induced transcriptional activation.

[1]  P. Hoodless,et al.  MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[2]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[3]  P. Hoodless,et al.  Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.

[4]  J. Massagué,et al.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin , 1994, Molecular and cellular biology.

[5]  K. Yamato,et al.  Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells* , 1999, The Journal of Biological Chemistry.

[6]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[7]  Xiao Zhen Zhou,et al.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules. , 1999, Science.

[8]  H. Lodish,et al.  The types II and III transforming growth factor-beta receptors form homo-oligomers , 1994, The Journal of cell biology.

[9]  T. Yoneda,et al.  Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.

[10]  R. Derynck,et al.  A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor , 1995, Nature.

[11]  T. Musci,et al.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.

[12]  P. Datta,et al.  Repression of transforming growth factor beta 1 promoter by the adenovirus oncogene E1A. Identification of a unique GC-rich sequence as a target for E1A repression. , 1994, The Journal of biological chemistry.

[13]  J. Massagué,et al.  The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. , 1997, Genes & development.

[14]  M. Barinaga New Clues to How Proteins Link Up to Run the Cell , 1999, Science.

[15]  Harold L. Moses,et al.  Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling* , 1998, The Journal of Biological Chemistry.

[16]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[17]  Raman Nambudripad,et al.  The ancient regulatory-protein family of WD-repeat proteins , 1994, Nature.

[18]  J. Massagué,et al.  TGF- SIGNAL TRANSDUCTION , 1998 .

[19]  T. Hunter,et al.  TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. , 1998, Genes & development.

[20]  David E. Clapham,et al.  New roles for G-protein (βγ-dimers in transmembrane signalling , 1993, Nature.

[21]  J. Schneider-Mergener,et al.  FAN, a Novel WD-Repeat Protein, Couples the p55 TNF-Receptor to Neutral Sphingomyelinase , 1996, Cell.

[22]  R. Derynck,et al.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.

[23]  Takeshi Imamura,et al.  Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.

[24]  C. Heldin,et al.  Transforming Growth Factor β1 Induces Nuclear Export of Inhibitory Smad7* , 1998, The Journal of Biological Chemistry.

[25]  R. Derynck,et al.  Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[26]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[27]  W. Vale,et al.  Smad8 mediates the signaling of the receptor serine kinase , 1997 .

[28]  H. Hamm,et al.  The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.

[29]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[30]  C. Heldin,et al.  Physical and Functional Interaction of Murine andXenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors* , 1998, The Journal of Biological Chemistry.

[31]  J. Massagué,et al.  SMADs: mediators and regulators of TGF-β signaling , 1998 .

[32]  K. Miyazono,et al.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[33]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[34]  J. Massagué,et al.  TGF-beta receptors and actions. , 1994, Biochimica et biophysica acta.

[35]  R. Derynck,et al.  The Type II Transforming Growth Factor (TGF)-β Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-β Response* , 1998, The Journal of Biological Chemistry.

[36]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[37]  R. Derynck,et al.  Physical and Functional Interactions between Type I Transforming Growth Factor β Receptors and Bα, a WD-40 Repeat Subunit of Phosphatase 2A , 1998, Molecular and Cellular Biology.

[38]  Xin Chen,et al.  A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.

[39]  R. Derynck,et al.  Homomeric interactions between type II transforming growth factor-beta receptors. , 1994, The Journal of biological chemistry.

[40]  D. Vaughan,et al.  Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[41]  R. Derynck,et al.  TGF- receptor signaling , 1997 .

[42]  A. Moustakas,et al.  The Types II and III Transforming Growth Factor-Receptors Form Homo-Oligomers , 2002 .

[43]  P. Hoodless,et al.  MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways , 1996, Cell.

[44]  H. Moses,et al.  Signal transduction by transforming growth factor‐β: A cooperative paradigm with extensive negative regulation , 1998, Journal of cellular biochemistry.

[45]  한평림 A Transcriptional Partner for MAD Proteins in TGF - b Signalling , 1996 .

[46]  J. Massagué,et al.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.

[47]  K. Kinzler,et al.  Characterization of human FAST-1, a TGFβ and activin signal transducer , 1998 .

[48]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[49]  R. Weinberg,et al.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Johnson,et al.  Residues in the WD repeats of Tup1 required for interaction with alpha2 , 1997, Molecular and cellular biology.

[51]  C. Wernstedt,et al.  Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling* , 1997, The Journal of Biological Chemistry.

[52]  A. V. van Zonneveld,et al.  Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. , 1991, The Journal of biological chemistry.

[53]  Steven Dyson,et al.  The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors , 1998, Cell.

[54]  K. Miyazono,et al.  Interaction of the Transforming Growth Factor-β Type I Receptor with Farnesyl-protein Transferase-α (*) , 1995, The Journal of Biological Chemistry.

[55]  H. Moses,et al.  Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor (*) , 1995, The Journal of Biological Chemistry.

[56]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[57]  Jeffrey L. Wrana,et al.  TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.

[58]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.